Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark one)

 

ý        QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2004

 

OR

 

o        TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _____________ to _____________.

 

Commission File No.: 000-20698

 

BROOKTROUT, INC.

(Exact Name of Registrant as Specified in Its Charter)

 

MASSACHUSETTS

 

04-2814792

(State or Other Jurisdiction of Incorporation or Organization)

 

(I.R.S. Employer Identification No.)

 

 

 

250 FIRST AVENUE, NEEDHAM, MASSACHUSETTS 02494

(Address of Principal Executive Offices) (Zip Code)

 

 

 

Registrant’s Telephone Number, Including Area Code: (781) 449-4100

 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý       No o

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes ý       No o

 

As of October 29, 2004, 12,729,420 shares of common stock, $.01 par value per share, were outstanding.

 

 

 



 

 

BROOKTROUT, INC.

FORM 10-Q FOR THE QUARTER ENDED SEPTEMBER 30, 2004

 

TABLE OF CONTENTS

 

 

 

Page

PART I FINANCIAL INFORMATION

 

Item 1.

Condensed Consolidated Financial Statements

1

 

Unaudited Condensed Consolidated Balance Sheets as of September 30, 2004 and December 31, 2003

1

 

Unaudited Condensed Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2004 and September 30, 2003

2

 

Unaudited Condensed Consolidated Statements of Comprehensive Income (Loss) for the Three and Nine Months Ended September 30, 2004 and September 30, 2003

3

 

Unaudited Condensed Consolidated Statements of Cash Flows for the Nine Months Ended September 30, 2004 and September 30, 2003

4

 

Notes to Unaudited Condensed Consolidated Financial Statements

5

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

11

 

Overview

11

 

Application of Critical Accounting Policies

11

 

Results of Operations

12

 

Liquidity and Capital Resources

16

 

Factors That May Affect Future Results

18

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

24

Item 4.

Controls and Procedures

25

 

 

 

 

PART II OTHER INFORMATION

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

26

Item 5.

Other Information

26

Item 6.

Exhibits

27

 

Signatures

28

 

Exhibit Index

29

 

 

“BROOKTROUT” and the “NEW NETWORK” are trademarks or registered trademarks of Brooktrout, Inc.

 

 



 

PART I FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

BROOKTROUT, INC.

UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)

 

 

September 30,
2004

 

December 31,
2003

 

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

 

$

30,722

 

$

28,081

 

Marketable debt securities

 

22,277

 

27,869

 

Accounts receivable (less allowances for doubtful accounts and sales returns of $558 at September 30, 2004 and $843 at December 31, 2003)

 

9,351

 

10,232

 

Inventory

 

3,747

 

4,465

 

Income tax receivable

 

124

 

433

 

Deferred tax assets

 

4,028

 

3,830

 

Prepaid expenses and other current assets

 

2,129

 

2,354

 

 

 

 

 

 

 

Total current assets

 

72,378

 

77,264

 

 

 

 

 

 

 

Equipment and furniture, less accumulated depreciation

 

2,248

 

2,245

 

Deferred tax assets

 

14,402

 

9,413

 

Intangible assets, less accumulated amortization

 

5,866

 

5,909

 

Other assets, less accumulated amortization

 

2,072

 

1,748

 

 

 

 

 

 

 

Total assets

 

$

96,966

 

$

96,579

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities:

 

 

 

 

 

Accounts payable

 

$

4,893

 

$

5,350

 

Accrued expenses and other

 

6,095

 

5,128

 

Accrued compensation and commissions

 

2,394

 

2,405

 

Accrued warranty costs

 

1,325

 

1,138

 

Customer deposits

 

728

 

758

 

 

 

 

 

 

 

Total current liabilities

 

15,435

 

14,779

 

 

 

 

 

 

 

Deferred rent and other long-term liabilities

 

130

 

146

 

 

 

 

 

 

 

Total liabilities

 

15,565

 

14,925

 

 

 

 

 

 

 

Commitments and contingencies (Note 8)

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity:

 

 

 

 

 

Preferred stock, $1.00 par value; authorized 100,000 shares; issued and outstanding, none

 

 

 

Common stock, $0.01 par value; authorized 80,000,000 shares at September 30, 2004 and 40,000,000 shares at December 31, 2003; issued 13,351,587 at September 30, 2004 and 12,937,019 at December 31, 2003

 

133

 

129

 

Additional paid-in capital

 

71,320

 

68,270

 

Accumulated other comprehensive loss

 

(141

)

(45

)

Notes receivable — officers

 

(9,845

)

(9,845

)

Retained earnings

 

24,622

 

26,942

 

Treasury stock, 348,237 shares at September 30, 2004 and 260,386 shares at December 31, 2003, at cost

 

(4,688

)

(3,797

)

 

 

 

 

 

 

Total stockholders’ equity

 

81,401

 

81,654

 

Total liabilities and stockholders’ equity

 

$

96,966

 

$

96,579

 

 

See notes to unaudited condensed consolidated financial statements.

 

 

1



 

BROOKTROUT, INC.

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

 

 

 

Three Months Ended September 30,

 

Nine Months Ended September 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Revenue

 

$

20,369

 

$

19,446

 

$

58,255

 

$

52,370

 

 

 

 

 

 

 

 

 

 

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

Cost of product sold

 

6,345

 

6,680

 

18,619

 

19,280

 

Research and development

 

4,373

 

4,455

 

13,705

 

13,868